Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
Carlo Visco(University of Verona), Ken H. Young(Duke Medical Center), Jane N. Winter(Northwestern University), Carlos E. Bueso‐Ramos(The University of Texas MD Anderson Cancer Center), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), T M Green(University of Southern Denmark), Stacey S. O’Neill(University of North Carolina at Chapel Hill), Eric D. Hsi(Mayo Clinic), M. Ponzoni, J. Han van Krieken(Radboud University Nijmegen), Y Li(Roche (Switzerland)), Zijun Y. Xu‐Monette(Duke University), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), J Tong(Second Affiliated Hospital of Zhejiang University), Attilio Orazi(Texas Tech University), Alexandar Tzankov(University of Basel), Magdalena Czader(Karolinska Institutet), Wei Ai(University of California, San Francisco), April Chiu(Mayo Clinic), Roberto N. Miranda(The University of Texas MD Anderson Cancer Center), Xia Zhao(Central South University), Youli Zu(Methodist Hospital), Wayne Tam(Cornell University), Brad S. Kahl(UW Health University Hospital), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Santiago Montes‐Moreno(Universidad de Cantabria), Liyun Wu(Roche (Switzerland)), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), R S Go(Gundersen Health System), Fan Zhou(Southwest Washington Medical Center), William W.L. Choi(Chinese University of Hong Kong), Weidong Wen(Washington University in St. Louis), Emanuele S.G. dʼAmore(Ospedale San Bortolo), L. Jeffrey Medeiros(Delaware Division of Libraries), Cherie H. Dunphy(Saint Louis University), Joan Etzell(University of California, San Francisco)
Cited by 362
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k